Episodic Migraine

Also known as: Migraine Headache, Episodic / Episodic Migraine Headache / Episodic migraine (disorder) / Migraine, unspecified / Migraine, unspecified, not intractable, without status migrainosus / Migraine NOS / Migraine headaches / Migraine headache / Migrainous headache / Migraine type headaches / Migraine Disorders / Migraine (disorder) / Migraine

Drug	Drug Name	Drug Description
DB16098	Atogepant	An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches.
DB12457	Rimegepant	An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults.

Drug	Drug Name	Target	Type
DB16098	Atogepant	Calcitonin gene-related peptide type 1 receptor	target
DB16098	Atogepant	Cytochrome P450 3A4	enzyme
DB16098	Atogepant	Solute carrier organic anion transporter family member 1B1	transporter
DB16098	Atogepant	Solute carrier organic anion transporter family member 1B3	transporter
DB16098	Atogepant	Solute carrier family 22 member 6	transporter
DB16098	Atogepant	Broad substrate specificity ATP-binding cassette transporter ABCG2	transporter
DB16098	Atogepant	ATP-dependent translocase ABCB1	transporter
DB16098	Atogepant	Solute carrier family 22 member 1	transporter
DB16098	Atogepant	Multidrug and toxin extrusion protein 1	transporter
DB12457	Rimegepant	Calcitonin gene-related peptide type 1 receptor	target
DB12457	Rimegepant	ATP-dependent translocase ABCB1	transporter
DB12457	Rimegepant	Broad substrate specificity ATP-binding cassette transporter ABCG2	transporter
DB12457	Rimegepant	Solute carrier organic anion transporter family member 1B1	transporter
DB12457	Rimegepant	Organic anion transporter 3	transporter
DB12457	Rimegepant	Solute carrier organic anion transporter family member 1B3	transporter
DB12457	Rimegepant	Solute carrier family 22 member 2	transporter
DB12457	Rimegepant	Multidrug and toxin extrusion protein 1	transporter
DB12457	Rimegepant	Cytochrome P450 3A4	enzyme
DB12457	Rimegepant	Cytochrome P450 2C9	enzyme

Drug	Drug Name	Phase	Status	Count
DB00945	Acetylsalicylic acid	Not Available	Withdrawn	1
DB06379	Calcitonin gene-related peptide	Not Available	Recruiting	3
DB14039	Erenumab	Not Available	Recruiting	2
DB14041	Fremanezumab	Not Available	Recruiting	2
DB14042	Galcanezumab	Not Available	Recruiting	2
DB01076	Atorvastatin	2	Recruiting	1
DB00297	Bupivacaine	2	Recruiting	1
DB00514	Dextromethorphan	2	Completed	1
DB14041	Fremanezumab	2	Completed	1
DB00959	Methylprednisolone	2	Recruiting	1
DB00908	Quinidine	2	Completed	1
DB16098	Atogepant	3	Active Not Recruiting	1
DB16098	Atogepant	3	Completed	5
DB16098	Atogepant	3	Recruiting	1
DB00083	Botulinum toxin type A	3	Active Not Recruiting	1
DB00083	Botulinum toxin type A	3	Recruiting	1
DB14040	Eptinezumab	3	Recruiting	1
DB14039	Erenumab	3	Completed	2
DB14042	Galcanezumab	3	Completed	1
DB14042	Galcanezumab	3	Recruiting	1
DB00281	Lidocaine	3	Completed	1
DB00281	Lidocaine	3	Unknown Status	1
DB09153	Sodium chloride	3	Completed	1
DB16098	Atogepant	4	Completed	1
DB14039	Erenumab	4	Completed	1
DB14042	Galcanezumab	4	Completed	1
DB01050	Ibuprofen	4	Completed	1
DB12457	Rimegepant	4	Completed	2
DB00953	Rizatriptan	4	Completed	1
DB15328	Ubrogepant	4	Completed	1